Anti-tumor activity of opaganib is mediated by multiple underlying mechanisms, including direct inhibition of cell proliferation [19], enhanced apoptosis of CCA cells through the upregulation of pro-apoptotic NOXA [21,22], and the induction of CCA cell autophagy [23]. Here, PMAIP1 is linked to cholangiocarcinoma.